Atlas Trials

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

Clinical trial NCT03173573 · COMPLETED

Trial details

NCT number
NCT03173573
Sponsor
Flatley Discovery Lab LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2017-06-27
Primary completion
2018-05-31
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.